Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Thiophene integrin inhibitors designed at BioChem Pharma

Feb. 2, 2001

Theratechnologies' ex vivo PDT cell therapy system enters clinical testing

Feb. 2, 2001

SafeScience gains additional patent rights to GBC-590

Feb. 2, 2001

YM BioSciences and SR Pharma to codevelop cancer vaccine

Feb. 2, 2001

Novogen phase I trial of anticancer drug phenoxodiol approved by FDA

Feb. 1, 2001

Trisenox moves into multiple myeloma clinical trials

Feb. 1, 2001

New peptoid MMP inhibitors useful for cancer, etc.

Feb. 1, 2001

Femara receives E.U. approval as first-line breast cancer therapy

Feb. 1, 2001

Preparation and antitumor activity of new xanthone compound from Asta Medica

Feb. 1, 2001

MTC-DOX assigned orphan drug status for liver cancer Rx by FDA

Feb. 1, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.